Publication Date

2015

Journal Title

World J Hepatol

Abstract

Inflammatory bowel disease (IBD) is composed of Crohn's disease and ulcerative colitis and is manifested by both bowel-related and extraintestinal manifestations. Recently the number of therapeutic options available to treat IBD has dramatically increased, with each new medication having its own mechanism of action and side effect profile. A complete understanding of the hepatotoxicity of these medications is important in order to distinguish these complications from the hepatic manifestations of IBD. This review seeks to evaluate the hepatobiliary complications of non-steroid based IBD medications and aide providers in the recognition and management of these side-effects.

Volume Number

7

Issue Number

27

Pages

2716-28

Document Type

Article

EPub Date

2015/12/09

Status

Faculty, Northwell Researcher

Facility

School of Medicine; Northwell Health

Primary Department

Gastroenterology

Additional Departments

Hepatology

PMID

26644815

DOI

10.4254/wjh.v7.i27.2716


Share

COinS